MorphoSys Announces that its Licensee Janssen Has Received U.S. FDA Approval for Tremfya(R) One-Press Patient-Controlled Injector for Adults with Moderate-to-Severe Plaque Psoriasis

Written by Brittney Marzullo-Sojeva on 27th February 2019. Posted in Client News.